首页|结直肠癌组织中SPON2、MGP表达及临床意义

结直肠癌组织中SPON2、MGP表达及临床意义

Expression and clinical significance of SPON2 and MGP in colorectal cancer tissue

扫码查看
目的 研究结直肠癌(CRC)组织中脊椎蛋白2(SPON2)、基质Gla蛋白(MGP)表达及与临床病理特征、预后的关系.方法 选取2018 年1 月—2020 年1 月南京市第一医院普外科收治行手术治疗CRC患者94 例.采用免疫组织化学法检测癌和癌旁组织中SPON2、MGP表达;分析SPON2、MGP表达与CRC患者临床病理特征及预后的关系;多因素Cox回归分析CRC患者预后影响因素.结果 CRC癌及癌旁组织中SPON2 阳性率分别为 65.96%(62/94)和6.38%(6/94),MGP阳性率分别为63.83%(60/94)和 8.51%(8/94),SPON2、MGP在CRC癌组织中的阳性率高于癌旁组织(χ2 =72.251、62.298,P均<0.001).低分化程度、TNM分期Ⅲ期及有淋巴结转移患者SPON2、MGP阳性率分别高于高中分化、TNM 分期 I~Ⅱ期及无淋巴结转移患者(χ2/P = 9.694/0.002、10.883/0.001、14.100/<0.001,14.785/<0.001、9.731/0.002、12.739/<0.001).SPON2 阳性组、阴性组3 年生存率分别为54.84%(34/62)和86.67%(26/30);MGP阳性组、阴性组3 年生存率分别为53.33%(32/60)和 87.50%(28/32).SPON2 阳性组、MGP阳性组3 年累积生存率低于SPON2 阴性组、MGP阴性组(χ2 =8.966、12.420,P =0.003、<0.001).肿瘤TNM分期Ⅲ期、低分化程度、伴淋巴结转移、SPON2 阳性、MGP阳性是影响CRC患者预后的独立危险因素[HR(95%CI)=1.768(1.226~2.551)、1.613(1.223~2.126)、1.600(1.167~2.194)、1.866(1.324~2.630)、1.315(1.151~1.503),均P<0.001].结论 CRC中SPON2、MGP表达升高,两者与CRC不良临床病理特征有关,是新的评估CRC患者预后的肿瘤标志物.
Objective To investigate the expression of spinal protein 2(SPON2)and matrix Gla protein(MGP)in colorectal cancer(CRC)tissue and their relationship with clinical pathological features and prognosis.Method Ninety-four CRC patients underwent surgery who were admitted to the General Surgery Department of Nanjing First Hospital from Janu-ary 2018 to January 2020 were selected.Immunohistochemical staining was used to detect the expression of SPON2 and MGP in cancer and adjacent tissues;Analyze the relationship between the expression of SPON2 and MGP and the clinical pathologicalcharacteristics and prognosis of CRC patients;Multivariate Cox regression analysis of prognostic factors in CRC patients.Results The positive rates of SPON2 in CRC cancer and adjacent tissues were 65.96%(62/94)and 6.38%(6/94),respectively,while the positive rates of MGP were 63.83%(60/94)and 8.51%(8/94),respectively.The positive rates of SPON2 and MGP in CRC cancer tissues were higher than those in adjacent tissues(χ2=72.251,62.298,both P<0.001).The positive rates of SPON2 and MGP in patients with TNM stage Ⅲ,low differentiation,and lymph node metastasis were higher than those in patients with TNM stage Ⅰ-Ⅱ,high differentiation,and no lymph node metastasis,respectively(χ2/P= 9.694/0.002,10.883/0.001,14.100/<0.001,14.785/<0.001,9.731/0.002,12.739/<0.001).The 3-year survival rates of SPON2 positive and negative groups were 54.84%(34/62)and 86.67%(26/30),respectively;The 3-year survival rates of MGP posi-tive and negative groups were 53.33%(32/60)and 87.50%(28/32),respectively.The 3-year cumulative survival rate of SPON2 positive group and MGP positive group is lower than that of SPON2 negative group and MGP negative group(χ2=8.966,12.420,P=0.003,<0.001).Tumor TNM stage Ⅲ,low differentiation,lymph node metastasis,SPON2 positive,and MGP positive are independent risk factors affecting the prognosis of CRC patients[HR(95%CI)=1.768(1.226-2.551),1.613(1.223-2.126),1.600(1.167-2.194),1.866(1.324-2.630),1.315(1.151-1.503),all P<0.001].Conclusion Elevated expression of SPON2 and MGP in CRC is associated with adverse clinical and pathological features of CRC,and they are new tumor markers for evaluating the prognosis of CRC patients.

Colorectal cancerSpinal protein 2Matrix Gla proteinPrognosis

杨同昕、董建宁、施雪松、曹红勇、杨维军

展开 >

210000 江苏省南京市第一医院普外科

结直肠癌 脊椎蛋白2 基质Gla蛋白 预后

江苏省卫生健康委基金

JH19137

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(2)
  • 5